CHM chimeric therapeutics limited

Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-50

  1. 717 Posts.
    lightbulb Created with Sketch. 585
    Of course I have, it's right there, 100 days complete response from CORE-NK (ie before consolidation therapy). Are you saying CHM's release is wrong or is lying? You seem to be changing your story now you've been exposed. You say above the deepened response to complete response was due to the transplant when the transplant hadn't even occurred by then!

    I'm surprised you didn't ask me to prove the world is round while I'm at it. This is a very promising result, I'll leave it to the forum readership to decide based on the posts above who has more credibility - me or you.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $11.72K 2.783M

Buyers (Bids)

No. Vol. Price($)
4 2757364 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 15260220 25
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.